WT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Wilms’ tumor 1 (WT1) gene, an oncogene that has been shown to be overexpressed in the wild-type form in the blast and crisis phase of chronic myelogenous leukemia and also acute lymphoblastic and myeloblastic leukemia, binds to the promoter region of BAG3 and acts as a transcriptional activator [112,113].